RhumbLine Advisers’s Marrone Bio Innovations, Inc. MBII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-75,752
| Closed | -$82K | – | 3332 |
|
|
2022
Q1 | $82K | Buy |
75,752
+3,305
| +5% | +$3.58K | ﹤0.01% | 2924 |
|
|
2021
Q4 | $52K | Sell |
72,447
-492
| -0.7% | -$353 | ﹤0.01% | 2978 |
|
|
2021
Q3 | $66K | Sell |
72,939
-4,335
| -6% | -$3.92K | ﹤0.01% | 3016 |
|
|
2021
Q2 | $128K | Buy |
77,274
+2,132
| +3% | +$3.53K | ﹤0.01% | 2957 |
|
|
2021
Q1 | $157K | Buy |
75,142
+100
| +0.1% | +$209 | ﹤0.01% | 2880 |
|
|
2020
Q4 | $94K | Buy |
75,042
+5,797
| +8% | +$7.26K | ﹤0.01% | 2972 |
|
|
2020
Q3 | $84K | Sell |
69,245
-17,788
| -20% | -$21.6K | ﹤0.01% | 2898 |
|
|
2020
Q2 | $102K | Sell |
87,033
-12,237
| -12% | -$14.3K | ﹤0.01% | 2964 |
|
|
2020
Q1 | $81K | Buy |
99,270
+29,640
| +43% | +$24.2K | ﹤0.01% | 2814 |
|
|
2019
Q4 | $70K | Sell |
69,630
-649
| -0.9% | -$652 | ﹤0.01% | 2902 |
|
|
2019
Q3 | $99K | Buy |
70,279
+53
| +0.1% | +$75 | ﹤0.01% | 2888 |
|
|
2019
Q2 | $105K | Buy |
70,226
+2,890
| +4% | +$4.32K | ﹤0.01% | 2924 |
|
|
2019
Q1 | $103K | Sell |
67,336
-685
| -1% | -$1.05K | ﹤0.01% | 2854 |
|
|
2018
Q4 | $100K | Buy |
68,021
+20,882
| +44% | +$30.7K | ﹤0.01% | 2884 |
|
|
2018
Q3 | $86K | Buy |
47,139
+12
| +0% | +$22 | ﹤0.01% | 2882 |
|
|
2018
Q2 | $87K | Buy |
+47,127
| New | +$87K | ﹤0.01% | 2885 |
|
|
2015
Q2 | – | Sell |
-10,140
| Closed | -$39K | – | 3118 |
|
|
2015
Q1 | $39K | Buy |
+10,140
| New | +$39K | ﹤0.01% | 3003 |
|